lung
diseas
princip
caus
morbid
mortal
patient
cystic
fibrosi
cf
fundament
caus
cf
recess
mutat
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
encod
chloridebicarbon
anion
channel
defect
cftr
respiratori
epithelium
alter
transepitheli
ion
transport
ph
regul
airway
surfac
hydrat
mucociliari
clearanc
variou
infect
bacteri
fungal
viral
proinflammatori
milieu
massiv
neutrophil
influx
subsequ
neutrophil
extracellular
trap
net
releas
result
accumul
extracellular
dna
cytotox
peptid
caus
persist
cf
lung
injuri
neutrophil
infiltr
airway
occur
secondari
presenc
cytokin
chemokin
includ
tumor
necrosi
complementderiv
chemoattract
eg
lipid
mediat
eg
leukotrien
hepoxillin
lipid
intermedi
sustain
neutrophil
influx
increas
neutrophil
respons
chemoattract
stimul
neutrophil
proinflammatori
secretori
oxid
burst
activ
infiltr
neutrophil
either
phagocytos
microbi
pathogen
gener
reactiv
oxygen
speci
ro
intracellular
kill
degranul
releas
cytotox
peptid
extracellular
kill
cast
net
dnamesh
ensnar
microbi
pathogen
netosi
neutrophil
releas
decondens
chromatin
coat
elastas
myeloperoxidas
mpo
cytotox
granular
proteas
neutrophil
compon
perpetu
sever
inflamm
character
cf
lung
diseas
excess
net
increas
viscos
endobronchi
secret
hamper
mucociliari
clearanc
eventu
airway
damag
infant
cf
show
peribronchi
neutrophil
infiltr
prior
establish
initi
infect
inflammatori
respons
increas
gradual
toddler
older
children
increas
mucu
viscos
mucu
plug
small
medium
size
bronchiol
older
patient
increas
level
airway
cytokin
chemoattract
eg
increas
neutrophil
influx
thu
aggrav
lung
complic
inflammatori
lung
condit
facilit
chronic
infect
select
group
bacteria
differ
stage
lung
diseas
figur
children
cf
pseudomona
aeruginosamedi
inflamm
upper
lower
airway
elev
neutrophil
count
level
free
neutrophil
proteas
contrast
staphylococcu
aureu
infect
primarili
relat
lower
airway
inflamm
infect
p
aeruginosa
aureu
addit
effect
exacerb
inflamm
upper
lower
airway
neutrophildomin
inflammatori
respons
observ
lower
upper
cf
airway
p
aeruginosa
pathogen
infect
lower
airway
enhanc
persist
chronic
inflammatori
respons
lead
persist
airway
damag
requir
lung
transplant
howev
surviv
lung
transplant
recipi
low
compar
solid
organ
transplant
often
complic
acut
cellular
reject
infect
develop
chronic
lung
allograft
dysfunct
clad
bronchiol
obliteran
bo
occasion
posttranspl
lymphoprolif
diseas
ptld
immunosuppress
therapi
use
minim
reject
risk
antibiot
use
treatment
bacteri
infect
airway
infect
cytokin
airway
surfac
liquid
asl
ph
affect
bactericid
activ
neutrophil
netosi
acidif
cf
bronchoalveolar
environ
report
therefor
detail
understand
molecular
mechan
netosi
includ
effect
reduc
ph
metabol
pathway
kinas
sodiumpotassium
channel
reactiv
oxygen
speci
ro
transcript
regul
would
help
identifi
potenti
therapeut
target
control
excess
netosi
without
alter
antimicrobi
function
neutrophil
cf
screen
fdaapprov
drug
cf
neutrophil
help
delin
netosi
mechan
identifi
potenti
netosi
regul
drug
treat
cf
lung
diseas
cystic
fibrosi
transmembran
conduct
regul
atpbind
cassett
abc
protein
two
transmembran
domain
cytoplasm
nucleotid
bind
domain
unlik
typic
abc
cftr
regulatori
domain
rdomain
connect
domain
interestingli
rdomain
regul
phosphoryl
campdepend
protein
kinas
pka
rdomain
phosphoryl
interact
nbd
vital
channel
activ
dephosphoryl
r
domain
inhibit
channel
open
howev
cftr
molecul
lack
r
domain
distal
delet
three
amino
acid
residu
show
compar
channel
open
rate
absenc
pka
suggest
rdomain
phosphoryl
cftr
allow
ion
conduct
wherea
lack
phosphoryl
result
channel
close
cftr
mutat
sever
influenc
age
diagnosi
onset
digest
symptom
peripher
blood
oxygen
differ
mutat
identifi
subsequ
organ
six
differ
class
tabl
class
nonsens
mutat
larg
delet
lead
prematur
stop
codon
eg
result
truncat
cftr
protein
class
ii
mutat
lead
improp
fold
transport
protein
cell
surfac
missens
mutat
infram
delet
eg
approxim
patient
cf
canada
copi
class
ii
mutat
addit
total
cf
popul
two
copi
mutat
therefor
identifi
effect
therapeut
option
treat
associ
dysregul
cf
high
import
class
iii
mutat
lead
gate
defect
cftr
membran
protein
due
missens
mutat
also
known
gate
mutat
eg
recent
clinic
studi
show
cftr
potenti
eg
ivacaftor
success
correct
defect
patient
mutat
class
iv
mutat
lead
disrupt
chlorid
conduct
capac
cftr
protein
missens
mutat
protein
misfold
eg
class
v
mutat
includ
missens
mutat
lead
decreas
cftr
protein
synthesi
result
low
abund
cell
surfac
eg
cell
surfac
cftr
protein
quickli
remov
degrad
high
turnov
class
vi
mutat
lead
lack
normal
cftr
function
ie
inadequ
hydrat
airway
mucu
layer
impair
mucociliari
movement
consequ
sever
cftr
mutat
ie
result
subsequ
cf
relat
physiolog
complic
mucou
dehydr
play
import
role
cf
acut
lung
diseas
exacerb
pulmonari
complic
airway
epitheli
cell
express
cftr
epitheli
sodium
channel
enac
cftr
typic
inhibit
enac
open
howev
defici
reduc
express
cftr
fail
inhibit
enac
open
accumul
na
ion
insid
cell
form
osmot
gradient
result
dehydr
asl
dehydr
asl
impair
ciliari
movement
subsequ
mucu
clearanc
cf
airway
human
cf
bronchial
cell
cultur
mous
model
overexpress
subunit
enac
show
increas
sodium
absorpt
asl
dehydr
adenosin
regul
asl
cftr
defect
atp
alon
regul
asl
enac
calciumactiv
chlorid
channel
cacc
normal
hydrat
mucu
layer
airway
allow
effect
mucociliari
clearanc
howev
human
cf
airway
inevit
face
asl
dehydr
believ
primari
caus
mucociliari
clearanc
failur
ultim
predispos
patient
increas
risk
chronic
infect
mortal
increas
mucu
viscos
cf
airway
believ
deriv
sever
factor
reduc
secret
enhanc
calciummedi
mucin
crosslink
consequ
mucu
thicken
mucu
thicken
also
direct
effect
asl
dehydr
concentr
mucin
amplifi
mucin
crosslink
addit
cf
airway
accumul
larg
amount
dna
deriv
neutrophil
actin
increas
mucu
viscos
although
cell
present
airway
lumen
mani
cf
patient
helper
tcell
predomin
cytokin
profil
abund
cytokin
sputum
cytokin
may
contribut
diseas
pathophysiolog
induc
goblet
cell
metaplasiahyperplasia
mucin
product
cytokin
predomin
cf
airway
consid
increas
neutrophil
recruit
convers
recent
studi
suggest
neutrophil
releas
arginas
deplet
arginin
prevent
tcell
expans
may
reason
cell
detect
neutrophilrich
cf
airway
lumen
although
mucu
dehydr
wellknown
contributor
lung
function
declin
cf
patient
accumul
neutrophil
net
increas
mucu
viscos
promot
pulmonari
exacerb
cystic
fibrosi
airway
character
inflamm
recurrentchron
bacteri
infect
lead
fatal
declin
pulmonari
function
eventu
respiratori
failur
notabl
earli
sign
lung
inflamm
preced
colon
infect
proinflammatori
marker
human
neutrophil
elastas
elev
cf
airway
milieu
perhap
convinc
evid
support
inflamm
primari
event
come
studi
conduct
cf
fetus
studi
show
increas
proinflammatori
cytokin
alreadi
found
cf
airway
fetal
develop
although
newborn
infant
cf
gener
thought
normal
lung
autopsi
cf
fetus
report
prenat
abnorm
airway
includ
loss
microvilli
airway
epitheli
cell
dilat
tracheal
submucos
gland
duct
furthermor
inflammatori
respons
bacteria
express
ratio
neutrophil
bacteria
exagger
disproportion
children
cf
compar
noncf
control
patient
nevertheless
studi
argu
inflamm
secondari
event
infect
reason
inconsist
studi
may
relat
differ
methodolog
experiment
condit
howev
gener
agreement
regard
event
occur
diseas
progress
cf
small
airway
initi
major
site
lung
diseas
earli
lung
structur
abnorm
eg
bronchiectasi
air
trap
detect
infant
cf
ct
scan
within
first
month
even
absenc
clinic
appar
lung
diseas
progress
structur
lung
diseas
infant
cf
associ
neutrophil
inflamm
pulmonari
infect
pulmonari
inflamm
reduc
lung
function
pulmonari
infect
exacerb
declin
lung
function
neutrophil
develop
occur
bone
marrow
follow
full
matur
peripher
blood
time
everi
day
approxim
billion
neutrophil
produc
bone
marrow
onebillion
releas
circul
neutrophil
howev
shortliv
cell
halflif
approxim
h
circul
neutrophil
releas
bloodstream
bone
marrow
attribut
varieti
cytokin
granulocyt
coloni
stimul
factor
gcsf
cxcmotif
ligand
chemokin
eg
neutrophil
chemokin
receptor
bind
ligand
stromal
deriv
factor
bone
marrow
stromal
cell
restrict
neutrophil
releas
circul
chemokin
gcsf
regul
neutrophil
cell
surfac
presenc
promot
neutrophil
flow
circul
develop
neutrophil
express
elev
level
matur
neutrophil
express
less
receptor
neutrophil
undergo
senesc
period
unrespons
behavior
chemoattract
suppress
ro
product
degranul
senesc
neutrophil
abund
suggest
neutrophil
transport
back
bone
marrow
clear
resid
macrophag
interestingli
matur
neutrophil
cf
patient
show
vari
profil
peripher
blood
matur
cf
neutrophil
express
reduc
level
howev
express
significantli
elev
cell
surfac
level
extravas
airway
secret
furthermor
granulocyt
cf
airway
chronic
fungal
colon
aspergillu
fumigatu
also
express
high
level
compar
healthi
control
express
profil
cf
neutrophil
may
highlight
import
receptor
avenu
investig
neutrophil
express
cftr
cell
surfac
phagolysosom
membran
interestingli
differenti
human
leukocyt
promyelocyt
cell
neutrophil
like
cell
result
increas
cftr
express
may
suggest
cftr
role
matur
neutrophil
given
function
chlorid
ion
transport
studi
suggest
vital
role
cftr
suppli
phagolysosom
chlorid
ion
use
bacteri
kill
phagolysosom
organel
encapsul
foreign
pathogen
fulli
form
shortli
phagocytosi
nadph
oxidas
ii
phagolysosom
gener
reactiv
oxygen
speci
includ
hydrogen
peroxid
myeloperoxidas
mpo
enter
phagosom
catalyz
convers
creat
hypochlor
acid
hocl
activ
ingredi
bleach
crucial
compon
phagolysosom
acidif
chlorin
microbi
compon
bacteri
degrad
bacteri
chlorin
neutrophil
detect
min
postphagocytosi
progress
increas
follow
min
presenc
cftr
correspond
antimicrobi
mechan
neutrophil
suggest
critic
role
fight
pathogen
may
compromis
cf
patient
differ
class
cftr
mutat
may
exert
vari
effect
neutrophil
dysfunct
baselin
chang
neutrophil
function
cf
patient
report
ineffect
neutrophil
function
includ
bacteri
kill
due
differ
cftr
genotyp
may
add
lung
complic
cf
patient
paradox
cf
lung
diseas
plenti
neutrophil
present
airway
lumen
unabl
effect
control
bacteri
infect
neutrophil
cf
airway
exhibit
dysfunct
phenotyp
deviat
wild
type
counterpart
studi
zhou
et
al
reveal
defect
hocl
product
bacteri
chlorin
cf
neutrophil
cftr
knockdown
cell
show
impair
neutrophilmedi
kill
bacteria
suggest
vital
role
cftr
kill
infecti
pathogen
compar
healthi
neutrophil
cf
neutrophil
display
increas
surviv
suppress
apoptosi
cell
interestingli
delay
apoptosi
correl
loss
cftr
function
inflamm
differ
cf
neutrophil
viabil
may
import
inher
innat
immun
dysfunct
interestingli
peripher
blood
cf
neutrophil
produc
significantli
ro
healthi
control
neutrophil
howev
tissu
locat
influenc
ro
product
airway
neutrophil
releas
less
ro
peripher
blood
neutrophil
variou
dysfunct
cf
neutrophil
significantli
compromis
abil
perform
antimicrobi
function
deviat
lethal
cf
patient
fight
foreign
pathogen
specif
microbi
pathogen
eg
bacteria
p
aeruginosa
klebsiella
pneumonia
aureu
fungi
aspergillu
fumigatu
candida
albican
virus
cytomegaloviru
influenza
bacteri
compon
eg
lp
certain
pharmacolog
agent
eg
pma
induc
neutrophil
nadph
oxidas
nox
insid
phagosom
electron
gener
nox
react
oxygen
produc
variou
ro
intermedi
eg
hocl
singlet
oxygen
singlet
oxygen
member
ro
famili
shown
essenti
format
net
depend
microbi
load
type
stimulu
neutrophil
switch
phagocytosi
netosi
phagocytosi
netosi
util
sever
similar
signal
event
netosi
neutrophil
granular
content
enter
nuclei
addit
phagosom
insid
nuclei
elastas
mpo
bind
chromatin
cleav
modifi
histon
respect
event
transcript
help
decondens
chromatin
cytotox
dnaprotein
complex
eventu
releas
nuclei
extracellular
space
net
addit
superoxid
remijsen
et
al
show
autophagi
also
requir
gener
net
emerg
evid
show
noxdepend
netosi
pathway
requir
cell
signal
involv
rafmekerk
kinas
pathway
detail
understand
mechan
involv
noxdepend
netosi
use
formul
therapeut
strategi
regul
netosi
cf
airway
futur
steril
injuri
also
induc
net
variou
pharmacolog
agent
eg
calcium
ionophor
microbi
secret
eg
ionomycin
cytokin
inert
particl
eg
uric
acid
crystal
lipid
intermedi
eg
platelet
activ
factor
paf
hepoxilin
contribut
induct
noxindepend
netosi
induc
increas
intracellular
calcium
increas
calcium
level
activ
calcium
depend
potassium
channel
eg
gener
mitochondri
ro
transloc
peptidylarginin
deiminas
enzym
nuclei
enzym
citrullin
histon
convert
posit
charg
arginin
noncharg
citrullin
destabil
interact
neg
charg
dna
histon
process
help
decondens
chromatin
releas
cytotox
net
extracellular
space
gener
noxindepend
pathway
consid
respons
steril
injuryrel
netosi
interestingli
cf
neutrophil
observ
dysfunct
mitochondri
ro
product
elev
intracellular
calcium
mitochondri
leakag
inher
characterist
cf
neutrophil
resembl
initi
step
noxindepend
pathway
netosi
therefor
cf
neutrophil
may
suscept
undergo
netosi
via
noxindepend
pathway
certain
agonist
eg
lp
bacteria
hepoxilin
lipid
intermedi
induc
noxdepend
independ
netosi
henc
cf
neutrophil
may
prone
undergo
netosi
via
netosi
pathway
regardless
type
netosi
noxdepend
net
serv
benefici
function
trap
kill
infecti
agent
contain
proinflammatori
agent
scaffold
nevertheless
excess
netosi
appear
contribut
viciou
cycl
dysregul
inflamm
infect
aggrav
perpetu
lung
diseas
patient
cf
cystic
fibrosi
airway
progress
damag
due
sever
inflamm
caus
proteas
cytotox
compound
oxygen
free
radic
possibl
excess
net
format
airway
epitheli
cell
host
immun
cell
bacteri
infect
exacerb
inflamm
result
damag
defici
cftr
function
epitheli
cell
caus
abnorm
signal
aberr
chemoattract
cytokin
product
dysregul
transcript
factor
inflammatori
mediat
environ
conduc
microbi
infect
dna
found
cf
airway
tradit
attribut
primarili
necrot
neutrophil
recent
suggest
dna
deriv
net
presenc
larg
quantiti
cytotox
peptid
granular
protein
net
deleteri
surround
tissu
net
accumul
cf
airway
result
dysregul
netosi
lack
clearanc
sever
compromis
respiratori
health
vast
amount
free
dna
accumul
cf
lung
contribut
increas
mucu
viscos
net
identifi
contribut
netdna
aggrav
mucu
dehydr
airway
clog
releas
cytotox
peptid
caus
tissu
injuri
differ
condit
cystic
fibrosi
acut
lung
injuri
infect
along
neutrophil
infiltr
inflamm
infect
also
import
featur
cf
microbiota
present
cf
airway
divers
chronic
pulmonari
infect
mainli
domin
opportunist
pathogen
includ
p
aeruginosa
burkholderia
cepacian
addit
inabl
neutrophil
net
erad
bacteria
dna
releas
neutrophil
also
promot
bacteri
colon
biofilm
format
neutrophil
cf
healthi
human
subject
equal
abl
cast
net
induc
p
aeruginosa
howev
clinic
strain
p
aeruginosa
acquir
resist
netmedi
kill
cours
infect
cf
airway
inflamm
massiv
neutrophil
infiltr
occur
earli
even
prior
appar
infect
cf
airway
cf
airway
milieu
imbalanc
cytokin
profil
shown
increas
activ
inflammatori
cytokin
gmcsf
effect
hostderiv
molecul
netosi
cf
clearli
known
allinal
data
suggest
massiv
influx
neutrophil
releas
neutrophil
dna
eg
net
dna
bronchiol
cf
lung
exacerb
diseas
patholog
increas
mucu
viscos
provid
better
environ
better
colon
infecti
bacteria
neutrophil
cf
patient
treatment
ivacaftor
show
diminish
activ
suggest
mutat
specif
function
modul
improv
neutrophil
function
reduc
netot
propens
may
help
reduc
inflamm
diseas
exacerb
collect
fact
argu
need
regul
neutrophil
activ
augment
clearanc
net
understand
mechan
netosi
associ
cf
could
help
identifi
new
effect
therapeut
option
deoxyribonucleas
dnase
digest
polymer
dna
henc
reduc
mucu
viscos
promot
mucu
clearanc
cf
airway
therefor
use
aerosol
recombin
human
dnase
dornas
alfa
attract
approach
allevi
dnarel
mucu
viscos
patient
cf
one
caveat
howev
inhibit
enzym
globular
actin
sinc
airway
cf
patient
contain
abund
dna
actin
issu
requir
attent
multipl
investig
look
dnase
immun
actinmedi
inhibit
chemic
modifi
plant
sourc
dnase
alidornas
alfa
develop
show
resist
actin
inhibit
clinic
studi
show
alidornas
alfa
improv
lung
function
compar
baselin
treatment
recombin
human
dornas
alfa
three
secretori
enzym
cleav
dna
interestingli
dnase
dnase
like
degrad
major
net
unlik
counterpart
dnase
like
resist
actin
make
protein
attract
compon
net
degrad
airway
although
commonli
use
dornas
alfa
caveat
clear
net
current
investig
aim
overcom
issu
modifi
dnase
show
promis
effect
use
therapeut
approach
neutrophil
cf
lung
also
releas
extracellular
proteas
destroy
lung
tissu
exogen
proteas
inhibitor
ineffect
inhibit
proteas
dnase
disrupt
ultrastructur
net
dnase
treatment
also
dramat
increas
proteolyt
activ
neutrophil
enzym
ne
cathepsin
g
proteas
bound
net
ultim
net
partial
cleav
net
fragment
sequest
activ
proteas
unresolv
clearanc
netprotein
complex
may
potenti
give
rise
autoimmun
respons
cf
patient
macrophag
also
known
mediat
net
clearanc
monocyt
leukocyt
differenti
macrophag
dendrit
cell
lung
unlik
neutrophil
chemoattract
activ
integrin
chemotaxi
defect
monocyt
cell
isol
cf
patient
also
replic
healthi
monocyt
expos
cftr
inhibitor
cftr
inh
interestingli
function
restor
cf
monocyt
treat
cftr
corrector
cflike
murin
lung
inflamm
model
monocyt
abund
lung
parenchyma
bronchoalveolar
lavag
suggest
applic
cf
condit
integrinindepend
monocyt
recruit
normal
transmigr
alveolar
space
impair
abund
airway
neutrophil
net
fact
macrophag
clear
net
lack
monocyt
airway
suggest
suppress
clearanc
net
attribut
excess
presenc
extracellular
dna
cf
sputum
current
understand
cf
pathophysiolog
emphas
dire
need
suppress
inflamm
infect
cf
lung
diseas
improv
mucociliari
movement
clearanc
pathogen
proinflammatori
agent
need
current
develop
therapi
use
target
netdna
inflammatori
lung
diseas
includ
dnase
antihiston
antibodi
antiproteas
duboi
et
al
show
treat
cf
sputum
dnase
increas
elastas
activ
chronic
inflammatori
lung
diseas
alreadi
elev
level
proteas
lead
lung
damag
increas
inflamm
antiproteas
use
therapi
suppress
activ
proteas
use
exogen
proteas
inhibitor
alon
shown
ineffect
cf
sputum
net
serv
reservoir
activ
proteas
protect
inhibit
use
antihiston
antibodi
also
shown
protect
netsmedi
lung
damag
transfusionrel
acut
lung
injuri
trali
mous
model
howev
use
antihiston
antibodi
highli
immunogen
induc
product
autoantibodi
potenti
promot
autoimmun
pseudomona
aeruginosa
biofilm
protect
pathogen
immun
system
netdna
biofilm
algin
cf
airway
also
contribut
mucu
viscos
respiratori
exacerb
move
forward
identif
novel
therapeut
approach
target
biofilm
architectur
promot
transform
vulner
plankton
form
import
fight
cf
lung
infect
overal
current
avail
therapi
reduc
symptom
slow
lung
diseas
progress
insuffici
effect
signific
associ
advers
effect
develop
new
earli
prevent
therapi
need
prevent
tissu
destruct
detail
inform
cf
model
molecular
mechan
netosi
oper
pathway
involv
kinas
sodium
potassium
channel
ro
transcript
factor
effect
modul
ph
inform
effort
identifi
potenti
target
control
excess
netosi
without
impair
requir
benefici
immun
function
neutrophil
identifi
drug
suppress
netosi
noxdepend
pathway
without
hamper
antimicrobi
activ
help
delin
mechan
drug
action
role
netosi
cf
inflamm
alter
normal
ph
report
bronchoalveolar
environ
cf
lung
neutrophil
intracellular
ph
lower
normal
tissu
ph
suggest
excess
neutrophil
infiltr
may
also
lower
overal
cf
bronchiolar
ph
intracellular
ph
also
play
import
role
activ
differ
neutrophil
granular
enzym
includ
mpo
elastas
import
studi
effect
modul
ph
netosi
context
cf
cystic
fibrosi
airway
larginin
defici
cf
airway
neutrophil
count
correl
arginas
level
increas
arginas
level
consid
respons
tcell
suppress
dysregul
cell
respons
cf
airway
may
play
import
role
virusrel
exacerb
bacteri
infect
understand
mechanist
detail
potenti
therapeut
approach
regul
tcellneutrophil
interact
could
also
help
reduc
pulmonari
exacerb
cf
airway
summari
neutrophil
first
line
defens
harm
agent
cf
neutrophil
identifi
vital
innat
immun
cell
infiltr
control
chronic
infect
airway
express
defect
cftr
cf
neutrophil
partli
respons
disabl
microbi
clearanc
perpetu
airway
inflamm
destruct
massiv
neutrophil
recruit
infiltr
netosi
cf
airway
attribut
worsen
lung
condit
dna
cytotox
granular
compon
contribut
mucos
clog
steril
damag
respect
although
dnase
proteas
inhibitor
current
use
neutral
issu
complet
etiolog
net
worsen
cf
airway
still
clear
therefor
understand
variou
molecular
mechan
regul
key
aspect
netosi
cf
airway
crucial
identifi
effect
novel
therapeut
approach
treat
cf
lung
diseas
